From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access-Reference-Cited by-同舟云学术

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access

Published:2023-05-30 Issue:1 Volume:22 Page:495-500
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Hotez Peter J.¹²,Adhikari Rakesh¹,Chen Wen-Hsiang¹,Chen Yi-Lin¹,Gillespie Portia¹,Islam Nelufa Y.¹,Keegan Brian¹,Tyagi Kundu Rakhi¹,Lee Jungsoon¹,Liu Zhuyun¹,Kimata Jason T.²,Oezguen Numan³⁴,Pollet Jeroen¹,Poveda Cristina¹,Razavi Kay¹,Ronca Shannon E.¹²,Strych Ulrich¹,Thimmiraju Syamala R.¹,Versteeg Leroy¹,Villar-Mondragon Maria Jose¹,Wei Junfei¹,Zhan Bin¹,Bottazzi Maria Elena¹²

Affiliation:

1. Texas Children’s Hospital Center for Vaccine Development, Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA

2. Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA

3. Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA

4. Department of Pathology, Texas Children’s Hospital, Houston, TX, USA

Funder

Fifth Generation, Inc

JPB Foundation

NIH/NIAID

Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

Baylor College of Medicine

Publisher

Informa UK Limited

Subject